Enhancing Horizon Scanning by utilizing pre-developed scenarios: analysis of current practice and specification of a process improvement to aid the identification of important 'weak signals'

This paper documents the Intuitive Logics scenario planning process and its relationship with horizon scanning activity in order to evaluate the separate and joint usefulness of these methods for anticipating the future. The specific objectives of this paper are to: (i) identify and differentiate scenario planning and horizon scanning methodologies (ii) discuss & evaluate their analytic underpinnings, and (iii) critically appraise their separate and combined value and effectiveness in relation to enhancing organizational preparedness for the future. Our analysis culminates with specifications to (iv) enhance the identification of ’weak signals’ in Horizon Scanning by utilizing a systematically broadened range of both negatively-valenced and positively-valenced scenario storylines

The influence of cytomegalovirus on expression of HLA-G and its ligand KIR2DL4 by human peripheral blood leucocyte subsets

HLA‐G is a non‐classical class I HLA antigen, normally expressed in high levels only on extravillous cytotrophoblast. It has immunosuppressive properties in pregnancy and has also been found to be upregulated on leucocytes in viral infection. In this study, proportions of all leucocyte subsets expressing HLA‐G were found to be low in healthy subjects positive or negative for cytomegalovirus (CMV). Significantly greater proportions of CD4+ CD69+ and CD56+ T cells expressed HLA‐G compared to other T cells. However, following stimulation with CMV antigens or intact CMV, proportions of CD4+, CD8+, CD69+ and CD56+ T cells, and also B cells expressing HLA‐G, were significantly increased in CMV+ subjects. Despite some subjects having alleles of HLA‐G associated with high levels of expression, no relationship was found between HLA‐G genotype and expression levels. Purified B cells from CMV+ subjects stimulated in mixed culture with CMV antigens showed significantly increased HLA‐G mRNA expression by real‐time polymerase chain reaction. Serum levels of soluble HLA‐G were similar in CMV− and CMV+ subjects but levels in culture supernatants were significantly higher in cells from CMV+ than from CMV− subjects stimulated with CMV antigens. The HLA‐G ligand KIR2DL4 was mainly expressed on NK cells and CD56+ T cells with no differences between CMV+ and CMV− subjects. Following stimulation with IL‐2, an increase in the proportion of CD56+ T cells positive for KIR2DL4 was found, together with a significant decrease in CD56dimCD16+ NK cells. The results show that CMV influences HLA‐G expression in healthy subjects and may contribute to viral immune evasion

HLA polymorphisms as incidence factor in the progression to end-stage renal disease in Brazilian patients awaiting kidney transplant

Chronic renal failure (CRF) leads in the majority of instances to end-stage renal disease (ESRD) requiring renal replacement therapy. Age, gender, genetics, race, hypertension, and smoking among others are factors associated with ESRD. Our interest was to evaluate the possible associations of class I and II HLA antigens with ESRD renal disease independent of other factors, among patients with CRF, having various diagnoses in the Brazilian population of the Sao Paulo state. So 21 HLA-A, 31 HLA-B, and 13 HLA-DR were detected in 105 patients who were compared with 160 healthy controls of both sexes who were not related to the patients evaluated until 2005. We calculated allelic frequencies, haplotypes frequencies, etiological fractions (EF), preventive fractions, and relative risks (RR). We compared demographic data of patients and controls. The antigens positively associated with ESRD were: HLA-A78 (RR = 30.31 and EF = 0.96) and HLA-DR11 (RR = 18.87 and EF = 0.65). The antigens HLAB14 (RR = 29.90 and EF = 0.75) was present at a significantly lower frequency among patients compared with controls. In contrast, no haplotype frequency showed statically significant associations. Further molecular studies may clarify types and subtypes of alleles involved with ESRD progression

Association of Interferon-gamma gene polymorphism (+874 T/A) with systemic sclerosis

Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq

Interieukin-17 and Kidney Allograft Outcome

Acute rejection episodes (ARE) are important complications that involve the interplay between mechanisms that maintain graft tolerance and promote rejection. The proinflammatory cytokine interieukin-17 (IL-17) has been implicated in many conditions in humans and mice. In kidney transplant patients, the evaluation IL-17 levels has been performed in only a few patients. We performed a cross-sectional study correlating quantitative IL-17 levels and clinical outcomes. Patients and methods. We studied 19 specimens from biopsies performed in patients (n = 19) who received isolated kidney grafts. ARE signs were present in 9 (47%) patients who provide specimens; whereas, 10 (53%) others showed no signs of rejection. Eighteen healthy control sample IL-17 underwent measurement, all of which were performed by an enzyme-linked immunosorbent assay method. We assessed other factors, such as the recipients demographic data, cold ischemia time, HLA mismatches, time elapsed from transplantation to the biopsy, posttransplantation status, antibody panel, donor type, and immunosuppressive treatment. Results. IL-17 levels were clearly increased among samples derived from patients with ongoing rejection (125.7 +/- 27.06 pg/mL) in contrast, to the nonrejection group, (30 +/- 13.32 pg/mL) (P < .05). Healthy controls showed no detectable IL-17 levels. Conclusions. These findings suggested that IL-17 was important in the pathophysiology of acute kidney rejection

Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially.

The immune checkpoint HLA-G prevents maternal rejection of the fetus and contributes in cancer invasion and acceptance of allografts. The 5' and 3' regulatory regions of the HLA-G gene are polymorphic and balancing selection probably maintains this variability. It is proposed that nucleotide variations may affect the level of HLA-G expression. To investigate this issue we aimed to analyze how haplotypes of the 3' untranslated region (3'UTR) with highest worldwide frequencies, namely UTR-1, UTR-2, UTR-3, UTR-4, UTR-5, UTR-18 and UTR-7, impact the expression of a luciferase reporter gene in vitro. Experiments performed with the HLA-G positive cell lines JEG-3 (choricarcinoma) and FON (melanoma), and with the HLA-G negative cell lines M8 (melanoma) and U251MG (glioblastoma) showed that the HLA-G 3'UTR polymorphism influences the response to endogenous cellular factors and may vary according to the cell type. UTR-5 and UTR-7 impact the activity of luciferase the most whereas UTR-2, UTR-3, UTR-4, and UTR-18 have intermediate impact, and UTR-1 has the lowest impact. These results corroborate the previous associations between amounts of plasma sHLA-G levels and 3'UTR haplotypes in healthy individuals and reinforce that 3'UTR typing may be a predictor of the genetic predisposition of an individual to express different levels of HLA-G

Bothrops jararaca

Bothrops jararaca (BJ) and Bothrops erythromelas (BE) are viper snakes found in South-Southeast and Northeast regions of Brazil, respectively. Snake venoms are bioactive neurotoxic substances synthesized and stored by venom glands, with different physiological and pharmacological effects, recently suggesting a possible preference for targets in cancer cells; however, mechanisms of snakes have been little studied. Here, we investigated the mechanism responsible for snake crude venoms toxicity in cultured cervical cancer cells SiHa and HeLa. We show that BJ and BE snake crude venoms exert cytotoxic effects to these cells. The percentage of apoptotic cells and cell cycle analysis and cell proliferation were assessed by flow cytometry and MTT assay. Detection of mitochondrial membrane potential (Rhodamine-123), nuclei morphological change, and DNA fragmentation were examined by staining with DAPI. The results showed that both the BJ and BE venoms were capable of inhibiting tumor cell proliferation, promoting cytotoxicity and death by apoptosis of target SiHa and HeLa cells when treated with BJ and BE venoms. Furthermore, data revealed that both BJ venoms in SiHa cell promoted nuclear condensation, fragmentation, and formation of apoptotic bodies by DAPI assay, mitochondrial damage by Rhodamine-123, and cell cycle block in the G1-G0 phase. BJ and BE venoms present anticancer potential, suggesting that both Bothrops venoms could be used as prototypes for the development of new therapies

Patients With Systemic Sclerosis Present Increased Dna Damage Differentially Associated With Dna Repair Gene Polymorphisms

Objective. Patients with systemic sclerosis (SSc) exhibit increased toxicity when exposed to genotoxic agents. In our study, we evaluated DNA damage and polymorphic sites in 2 DNA repair genes (XRCC1 Arg399Gln and XRCC4 Ile401Thr) in patients with SSc. Methods. A total of 177 patients were studied for DNA repair gene polymorphisms. Fifty-six of them were also evaluated for DNA damage in peripheral blood cells using the comet assay. Results. Compared to controls, the patients as a whole or stratified into major clinical variants (limited or diffuse skin involvement), irrespective of the underlying treatment schedule, exhibited increased DNA damage. XRCC1 (rs: 25487) and XRCC4 (rs: 28360135) allele and genotype frequencies observed in patients with SSc were not significantly different from those observed in controls; however, the XRCC1 Arg399Gln allele was associated with increased DNA damage only in healthy controls and the XRCC4 Ile401Thr allele was associated with increased DNA damage in both patients and controls. Further, the XRCC1 Arg399Gln allele was associated with the presence of antinuclear antibody and anticentromere antibody. No association was observed between these DNA repair gene polymorphic sites and clinical features of patients with SSc. Conclusion. These results corroborate the presence of genomic instability in SSc peripheral blood cells, as evaluated by increased DNA damage, and show that polymorphic sites of the XRCC1 and XRCC4 DNA repair genes may differentially influence DNA damage and the development of autoantibodies. Copyright © 2014. All rights reserved.413458465Domsic, R.T., Medsger Jr., T.A., Connective tissue diseases: Predicting death in SSc: Planning and cooperation are needed (2011) Nat Rev Rheumatol, 7, pp. 628-630Van Bon, L., Cossu, M., Radstake, T.R., An update on an immune system that goes awry in systemic sclerosis (2011) Curr Opin Rheumatol, 23, pp. 505-510Abraham, D.J., Varga, J., Scleroderma: From cell and molecular mechanisms to disease models (2005) Trends in Immunology, 26 (11), pp. 587-595. , DOI 10.1016/j.it.2005.09.004, PII S1471490605002395, Autoimmunity Special IssueAbraham, D., Distler, O., How does endothelial cell injury start? The role of endothelin in systemic sclerosis (2007) Arthritis Res Ther, 9 (SUPPL. 2), pp. S2Evans, M.D., Cooke, M.S., Oxidative damage to DNA in non-malignant disease: Biomarker or biohazard? (2006) Genome Dyn, 1, pp. 53-66Tsuruta, D., Ohzono, A., Ishii, N., Ono, F., Hamada, T., Dainichi, T., Overlap syndrome comprised of systemic sclerosis and systemic lupus erythematosus associated with spinocerebellar ataxia type 6 and MALT lymphoma (2013) Eur J Dermatol, 23, p. 117Lee, K.-J., Dong, X., Wang, J., Takeda, Y., Dynan, W.S., Identification of human autoantibodies to the DNA ligase IV/XRCC4 complex and mapping of an autoimmune epitope to a potential regulatory region (2002) Journal of Immunology, 169 (6), pp. 3413-3421Lo, S.F., Wan, L., Huang, C.M., Lin, H.C., Chen, S.Y., Liu, S.C., Genetic polymorphisms of the DNA repair gene UNG are associated with the susceptibility of rheumatoid arthritis (2012) Rheumatol Int, 32, pp. 3723-3727Bassi, C., Xavier, D.J., Palomino, G., Nicolucci, P., Soares, C., Sakamoto-Hojo, E., Efficiency of the DNA repair and polymorphisms of the XRCC1, XRCC3 and XRCC4 DNA repair genes in systemic lupus erythematosus (2008) Lupus, 17, pp. 988-995Housset, E., Emerit, I., Baulon, A., De Grouchy, J., Anomalies chromosomiques dans la sclérodermie géné ralisée. Une étude de 6 patients (French). Chromosome anomalies in generalized scleroderma. A study of 6 patients (1969) C R Acad Sci Hebd Seances Acad Sci D, 269, pp. 413-416Artlett, C.M., Black, C.M., Briggs, D.C., Stevens, C.O., Welsh, K.I., Telomere reduction in scleroderma patients: A possible cause for chromosomal instability (1996) Br J Rheumatol, 35, pp. 732-737Majone, F., Zamboni, D., Cozzi, F., Montaldi, A., Grypiotis, P., Luisetto, R., Favaro, M., Ruffatti, A., Unstabilized DNA breaks in lymphocytes of patients with systemic sclerosis (2006) European Journal of Dermatology, 16 (3), pp. 258-261Martins, E.P., Fuzzi, H.T., Kayser, C., Alarcon, R.T., Rocha, M.G., Chauffaille, M.L., Increased chromosome damage in systemic sclerosis skin fibroblasts (2010) Scand J Rheumatol, 39, pp. 398-401Fenech, M., The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations (1993) Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 285 (1), pp. 35-44. , DOI 10.1016/0027-5107(93)90049-LPorciello, G., Scarpato, R., Storino, F., Migliore, L., Ferri, C., Cagetti, F., Morozzi, G., Galeazzi, M., Chromosome aberrations in Raynaud's phenomenon (2004) European Journal of Dermatology, 14 (5), pp. 327-331Burt, R.K., Kallunian, K., Patel, D., Thomas, J., Yeager, A., Traynor, A., Heipe, F., Snowden, J., The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: Concerns over the use of total-body irradiation in systemic sclerosis (2004) Bone Marrow Transplantation, 34 (9), pp. 745-751. , DOI 10.1038/sj.bmt.1704671Masson, M., Niedergang, C., Schreiber, V., Muller, S., Menissier-De, M.J., De Murcia, G., XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage (1998) Molecular and Cellular Biology, 18 (6), pp. 3563-3571Caldecott, K.W., Aoufouchi, S., Johnson, P., Shall, S., XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro (1996) Nucleic Acids Research, 24 (22), pp. 4387-4394. , DOI 10.1093/nar/24.22.4387Thompson, L.H., West, M.G., XRCC1 keeps DNA from getting stranded (2000) Mutation Research - DNA Repair, 459 (1), pp. 1-18. , DOI 10.1016/S0921-8777(99)00058-0, PII S0921877799000580Duarte, M.C., Colombo, J., Rossit, A.R.B., Caetano, A., Borim, A.A., Wornrath, D., Silva, A.E., Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and grastic cancer (2005) World Journal of Gastroenterology, 11 (42), pp. 6593-6600Zhang, H., Li, W., Franklin, M.J., Dudek, A.Z., Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: A meta-analysis (2011) Anticancer Res, 31, pp. 3945-3952Sturgis, E.M., Castillo, E.J., Li, L., Zheng, R., Eicher, S.A., Clayman, G.L., Strom, S.S., Wei, Q., Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck (1999) Carcinogenesis, 20 (11), pp. 2125-2129. , DOI 10.1093/carcin/20.11.2125Abdel-Rahman, S.Z., Soliman, A.S., Bondy, M.L., Omar, S., El-Badawy, S.A., Khaled, H.M., Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt (2000) Cancer Lett, 159, pp. 79-86Shen, H., Xu, Y., Qian, Y., Yu, R., Qin, Y., Zhou, L., Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population (2000) Int J Cancer, 88, pp. 601-606Yu, C.L., Huang, M.H., Tsai, C.Y., Tsai, Y.Y., Tsai, S.T., Sun, K.H., The effect of human polyclonal anti-dsDNA autoantibodies on apoptotic gene expression in cultured rat glomerular mesangial cells (1998) Scand J Rheumatol, 27, pp. 54-60Duell, E.J., Millikan, R.C., Pittman, G.S., Winkel, S., Lunn, R.M., Tse, C.-K.J., Eaton, A., Bell, D.A., Polymorphisms in the DNA repair gene XRCC1 and breast cancer (2001) Cancer Epidemiology Biomarkers and Prevention, 10 (3), pp. 217-222Zhou, W., Liu, G., Miller, D.P., Thurston, S.W., Xu, L.L., Wain, J.C., Lynch, T.J., Christiani, D.C., Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk (2003) Cancer Epidemiology Biomarkers and Prevention, 12 (4), pp. 359-365Lees-Miller, S.P., Meek, K., Repair of DNA double strand breaks by non-homologous end joining (2003) Biochimie, 85 (11), pp. 1161-1173. , DOI 10.1016/j.biochi.2003.10.011Ford, B.N., Ruttan, C.C., Kyle, V.L., Brackley, M.E., Glickman, B.W., Identification of single nucleotide polymorphisms in human DNA repair genes (2000) Carcinogenesis, 21, pp. 1977-1981Burma, S., Chen, B.P.C., Chen, D.J., Role of non-homologous end joining (NHEJ) in maintaining genomic integrity (2006) DNA Repair, 5 (9-10), pp. 1042-1048. , DOI 10.1016/j.dnarep.2006.05.026, PII S1568786406001650, Mechanisms of Chromosomal TranslocationsMasi, A.T., Rodnan, G.P., Medsger, T.A., Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Arthritis and Rheumatism, 23 (5), pp. 581-590Carwile L.Roy, E., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger Jr., T.A., Wollheim, F., Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis (1988) Journal of Rheumatology, 15 (2), pp. 202-205Miller, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells (1988) Nucleic Acids Res, 16, p. 1215Relton, C.L., Daniel, C.P., Hammal, D.M., Parker, L., Tawn, E.J., Burn, J., DNA repair gene polymorphisms, pre-natal factors and the frequency of somatic mutations in the glycophorin-A gene among healthy newborns (2004) Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 545 (1-2), pp. 49-57. , DOI 10.1016/j.mrfmmm.2003.09.007Migliore, L., Bevilacqua, C., Scarpato, R., Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus (SLE) and systemic sclerosis (SS) patients (1999) Mutagenesis, 14 (2), pp. 227-231Porciello, G., Scarpato, R., Storino, F., Cagetti, F., Marcolongo, R., Migliore, L., L'alta frequenza di micronuclei spontanei osservati nei linfociti di pazienti con sclerosi sistemica: Risultati preliminari (Italian). The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results (2002) Reumatismo, 54, pp. 36-39Porciello, G., Scarpato, R., Ferri, C., Storino, F., Cagetti, F., Morozzi, G., Bellisai, F., Galeazzi, M., Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon (2003) Journal of Rheumatology, 30 (6), pp. 1244-1247McCurdy, D., Tai, L.-Q., Frias, S., Wang, Z., Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis (1997) Radiation Research, 147 (1), pp. 48-54. , DOI 10.2307/3579442McConnell, J.R., Crockard, A.D., Cairns, A.P., Bell, A.L., Neutrophils from systemic lupus erythematosus patients demonstrate increased nuclear DNA damage (2002) Clinical and Experimental Rheumatology, 20 (5), pp. 653-660Derk, C.T., Associations of breast cancer development in patients with systemic sclerosis: An exploratory study (2007) Clin Rheumatol, 26, pp. 1615-1619Lipsky, P.E., Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphoctye proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes (1984) Journal of Clinical Investigation, 73 (1), pp. 53-65Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., Revillard, J.-P., Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells (1998) Journal of Clinical Investigation, 102 (2), pp. 322-328O'Donovan, P., Perrett, C.M., Zhang, X., Montaner, B., Xu, Y.-Z., Harwood, C.A., McGregor, J.M., Karran, P., Medicine: Azathioprine and UVA light generate mutagenic oxidative DNA damage (2005) Science, 309 (5742), pp. 1871-1874. , DOI 10.1126/science.1114233Sampaio-Barros, P.D., Bortoluzzo, A.B., Marangoni, R.G., Rocha, L.F., Del Rio, A.P., Samara, A.M., Survival, causes of death, and prognostic factors in systemic sclerosis: Analysis of 947 Brazilian patients (2012) J Rheumatol, 39, pp. 1971-1978Kamanli, A., Naziroglu, M., Aydilek, N., Hacievliyagil, C., Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis (2004) Cell Biochemistry and Function, 22 (1), pp. 53-57. , DOI 10.1002/cbf.1055Simonini, G., Cerinic, M.M., Generini, S., Zoppi, M., Anichini, M., Cesaretti, C., Pignone, A., Cagnoni, M., Oxidative stress in systemic sclerosis (1999) Molecular and Cellular Biochemistry, 196 (1-2), pp. 85-91. , DOI 10.1023/A:1006922313774Kerr, L.D., Spiera, H., Scleroderma in association with the use of bleomycin: A report of 3 cases (1992) J Rheumatol, 19, pp. 294-296Goode, H.F., Webster, N.R., Free radicals and antioxidants in sepsis (1993) Critical Care Medicine, 21 (11), pp. 1770-1776Grob, M., Wyss, M., Spycher, M.A., Dommann, S., Schinzel, A., Burg, G., Trueb, R.M., Histopathologic and ultrastructural study of lupus-like skin lesions in a patient with Bloom syndrome (1998) Journal of Cutaneous Pathology, 25 (5), pp. 275-278. , DOI 10.1111/j.1600-0560.1998.tb01733.xMakker, S.P., Widstrom, R., Huang, J., Membranous nephropathy, interstitial nephritis, and Fanconi syndrome - Glomerular antigen (1996) Pediatric Nephrology, 10 (1), pp. 7-13. , DOI 10.1007/BF00863427Griswold, W.R., Krous, H.F., Reznik, V., Lemire, J., Wilson, N.W., Bastian, J., Spiegelberg, H., The syndrome of autoimmune interstitial nephritis and membranous nephropathy (1997) Pediatric Nephrology, 11 (6), pp. 699-702. , DOI 10.1007/s004670050369Brem, R., Fernet, M., Chapot, B., Hall, J., The methyl methanesulfonate induced S-phase delay in XRCC1-deficient cells requires ATM and ATR (2008) DNA Repair, 7, pp. 849-857Fontana, L., Bosviel, R., Delort, L., Guy, L., Chalabi, N., Kwiatkowski, F., Satih, S., Bernard-Gallon, D.J., DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort (2008) Anticancer Research, 28 (3 B), pp. 1853-1856Wong, R.H., Chang, S.Y., Ho, S.W., Huang, P.L., Liu, Y.J., Chen, Y.C., Polymorphisms in metabolic GSTP1 and DNA-repair XRCC1 genes with an increased risk of DNA damage in pesticide-exposed fruit growers (2008) Mutat Res, 654, pp. 168-175Eilat, D., Anderson, W.F., Structure-function correlates of autoantibodies to nucleic acids. Lessons from immunochemical, genetic and structural studies (1994) Molecular Immunology, 31 (18), pp. 1377-1390. , DOI 10.1016/0161-5890(94)90154-6Waris, G., Alam, K., Immunogenicity of superoxide radical modified-DNA: Studies on induced antibodies and SLE anti-DNA autoantibodies (2004) Life Sciences, 75 (22), pp. 2633-2642. , DOI 10.1016/j.lfs.2004.04.034, PII S002432050400654XGarg, D.K., Ali, R., Reactive oxygen species modified polyguanylic acid: Immunogenicity and implications for systemic autoimmunity (1998) Journal of Autoimmunity, 11 (4), pp. 371-378. , DOI 10.1006/jaut.1998.0208Lei, Y.-C., Hwang, S.-J., Chang, C.-C., Kuo, H.-W., Luo, J.-C., Chang, M.J.W., Cheng, T.-J., Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers (2002) Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 519 (1-2), pp. 93-101. , DOI 10.1016/S1383-5718(02)00127-4, PII S138357180200127